|
|
|
Day 1 |
|
Tuesday, October 19, 2010 |
| 11:00 AM - 12:00 PM | | Pharmacotherapies for Vascular Disease: Adjuncts or Replacements for Intervention
Moderator: Krishna Rocha-Singh, MD
Panel: Joshua Beckman, MD; Michel Makaroun, MD; John Rundback, MD
|
| 11:00 AM - 12:00 PM | | Disease-Based Carotid Treatment: Which Patient Populations Are Best Served by Stents, CEA or Medications
Moderator: Tony Das, MD
Panel: Nick Hopkins, MD; D. Christopher Metzger, MD; Mahmood Razavi, MD; Benjamin Starnes, MD
|
Day 2 |
|
Wednesday, October 20, 2010 |
| 10:45 AM - 11:45 AM | | How to Save the Patient With Massive PE
Moderator: Gary Ansel, MD
Panel: Melina Kibbe, MD; Michel Makaroun, MD; Bob Smouse, MD; Daniel Sze, MD
|
| 10:45 AM - 11:45 AM | | Optimal Central Vein Stenosis Treatment
Moderator: Michael Dake, MD
Panel: Donald Jacobs, MD; Alan Matsumoto, MD; Stephen Ramee, MD
|
| 4:30 PM - 5:30 PM | | Carotid Stent Techniques We Utilize to Decrease our TIA and Stroke Rates
Moderator: Timothy Sullivan, MD
Panel: Mark Burket, MD; William Gray, MD; D. Christopher Metzger, MD; Bob Smouse, MD
|
| 4:30 PM - 5:30 PM | | In-Stent Restenosis: Does Surveillance and Treatment Prolong Patency?
Moderator: Michael R. Jaff, DO
Panel: Lawrence Garcia, MD; Melina Kibbe, MD; Gustavo Oderich, MD; Christopher White, MD
|
Day 3 |
|
Thursday, October 21, 2010 |
| 9:00 AM - 10:00 AM | | Dealing With International Literature and the Off-Label Issue in the United States: Should You Treat Patients With Less Than the Best?
Moderator: John Kaufman, MD
Panel: Gary Ansel, MD; Michael R. Jaff, DO; Anne Roberts, MD
|
| 9:00 AM - 10:00 AM | | Disease-Based Ulcer Care: How to Incorporate All the Players Successfully
Moderator: John Laird, MD
Panel: Bruce Gray, DO; Stephen Kee, MD; Richard Neville, MD
|
|
|